News
The implant is designed to address cartilage defects in the knee that cause persistent pain, according to a press release from the company.
U.S. health agencies announced that the food industry will begin "phasing out" eight artificial food dyes in the coming years ...
The Department of Health and Human Services is calling on companies to phase out all petroleum-based dyes by the end of next ...
Pharmaceutical giant Eli Lilly alleges the companies are selling illegal off-brand versions of its best-selling diabetes and ...
The FDA announced its plan to phase out petroleum-based synthetic dyes from the U.S.’s food supply. Here are the popular ...
The FDA has approved the first ever RNA interference drug – Alnylam’s Onpattro (patisiran) for the nerve damage caused by the rare disease hereditary transthyretin-mediated amyloidosis (hATTR ...
BD (NYSE: BDX) announced today that it received FDA 510(k) clearance for its Phasix ST umbilical hernia patch.
But on Monday, the US Supreme Court heard oral arguments in a case that could gut the part of the Affordable Care Act that ...
Sometimes the short, soft hits make the big difference. His playing time limited this season, Starling Marte stepped to the plate with the chance to give the New York Mets a 4-3, ...
14h
Medical Device Network on MSNVivasure wins CE mark for bioresorbable PerQseal Elite deviceVivasure hope to find room in a competitive market with its surtureless implant that is absorbed 180 days after vessel ...
A no-contest clause is designed to discourage beneficiaries from disputing the terms of a will, but inheritance laws in India do not explicitly recognise or prohibit such clauses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results